ByteDance's Anew Labs reportedly raises US$290M as AI drug discovery gains momentum
<p class="P1" data-start="82" data-end="344">ByteDance has completed a US$290 million funding round for Anew Labs, its AI drug-discovery business spun off from the Chinese technology group, valuing the company at US$1.5 billion, according to <em>Reuters.</em> ByteDance will retain a 56% stake following the fundraising.
Read original article ↗
Related Articles
CJ ENM eyes European growth with major brand push in Poland
CJ ENM, the Korean entertainment powerhouse behind hits like "Parasite" and Studio Dragon dramas, is widening its reach
Hansae Mobility increases commitment in Uzbekistan
Senior executives from Hansae Yes24 Group attended a Korea-Uzbekistan business forum in Seoul as the conglomerate moves
This session will explore how early-stage companies are building teams where humans and AI agents work alongside each ot